Treatment with FOXO4-DRI at 25 M in serum-limited senescent fibroblast and keloid organ culture models promoted apoptosis, decreased G0/G1 phase cells, and induced p53-pS15 nuclear exclusion confirmed by Annexin V-FITC/PI apoptosis assays and TUNEL staining of keloid organ cultures at days 3, 7, and 10
Key Indications: Circadian rhythm disruption and sleep-wake imbalance Age-related neuroendocrine changes Longevity and healthy aging support Vascular and microcirculatory support Recommended Dosage 12 sprays sublingually, once daily or as directed by your healthcare professional
The complete COA library is also searchable by product and task number
localized joint or tendon injuries respond better to injection near the affected structure
Led by Aloni Le, DNP, ARNP, FNP-C , a Board-Certified Nurse Practitioner with more than 13 years of advanced medical experience, our treatments are carefully designed to deliver what your body needs safely and effectively